RANZCP homepage
Date
4 October 2023
6pm AEDT
Location
OnlineOrganised by
RANZCPDelivery
Online
In 2022, the RANZCP commissioned an independent review of the College’s approach to the development of clinical practice guidelines (CPG) for psychiatry in Australia and Aotearoa/New Zealand.
The review has been completed, and the College’s Future Development of CPGs Steering Group has presented a set of recommendations to the RANZCP Board, all of which have been accepted.
Join Sharon McGowan, CEO of RANZCP, and a RANZCP Board member as they give members an overview of the College’s new approach to Best Practice Resources.
To provide examples of ways to approach guidelines, the College has also invited representatives from the Australian Living Evidence Collaboration (ALEC) to join the webinar panel and discuss their work around digital technologies and living clinical guidelines.
Australian Living Evidence Collaboration (ALEC) is a world-first initiative that brings together leading experts in evidence synthesis, guideline development and digital technologies to build a next generation system for delivering reliable, accessible, up-to-date evidence in health.
Professor Tari Turner, Professor Julian Elliot and Professor Caroline Homer AO, will be discussing what ALEC is, the work done in living clinical guidelines and the vision for the future.
Presenters
Professor Caroline Homer AO
Professor Caroline Homer AO is Deputy Director, Gender Equity, Diversity and Inclusion at the Burnet Institute and Chair of the NHMRC. She is part of the new living guidelines for pregnancy and postnatal care called LEAPP (Living Evidence for Antenatal and Postpartum care) and Chair of the Steering Committee for the National Clinical Evidence Taskforce which led the development of the COVID-19 living guidelines.
Professor Caroline Homer AO is Deputy Director, Gender Equity, Diversity and Inclusion at the Burnet Institute and Chair of the NHMRC. She is part of the new living guidelines for pregnancy and postnatal care called LEAPP (Living Evidence for Antenatal and Postpartum care) and Chair of the Steering Committee for the National Clinical Evidence Taskforce which led the development of the COVID-19 living guidelines.
Professor Tari Turner
Professor Tari Turner is the Academic Director of the Australian Living Evidence Collaboration at Cochrane Australia, School of Public Health and Preventive Medicine within Monash University. Professor Turner's passion is supporting evidence-based decision making and the implementation of world class, up to date health information to ensure the best outcomes for patients. Seeing research make a positive difference is the driving force behind Professor Turner's work and the work of the Australian Living Evidence Collaboration.
Professor Tari Turner is the Academic Director of the Australian Living Evidence Collaboration at Cochrane Australia, School of Public Health and Preventive Medicine within Monash University. Professor Turner's passion is supporting evidence-based decision making and the implementation of world class, up to date health information to ensure the best outcomes for patients. Seeing research make a positive difference is the driving force behind Professor Turner's work and the work of the Australian Living Evidence Collaboration.
Professor Julian Elliot
Professor Julian Elliott is one of the world’s leading researchers in the use of technology for evidence synthesis. He developed the Living Evidence model, which improves the currency of high-quality evidence and is now being adopted worldwide, including by the World Health Organization and other major guideline groups. Prof Elliott was the founding Chair of the Australian Living Evidence Consortium and established the Australian National COVID-19 Clinical Evidence Taskforce, both based at Cochrane Australia within Monash University’s School of Public Health and Preventive Medicine. Prof Elliott is also the co-founder and CEO of the Future Evidence Foundation, which produces Covidence, a non-profit software platform for systematic reviews. In 2017 Prof Elliott was the recipient of the Australian Health Minister’s Award for Excellence in Health and Medical Research.
Professor Julian Elliott is one of the world’s leading researchers in the use of technology for evidence synthesis. He developed the Living Evidence model, which improves the currency of high-quality evidence and is now being adopted worldwide, including by the World Health Organization and other major guideline groups. Prof Elliott was the founding Chair of the Australian Living Evidence Consortium and established the Australian National COVID-19 Clinical Evidence Taskforce, both based at Cochrane Australia within Monash University’s School of Public Health and Preventive Medicine. Prof Elliott is also the co-founder and CEO of the Future Evidence Foundation, which produces Covidence, a non-profit software platform for systematic reviews. In 2017 Prof Elliott was the recipient of the Australian Health Minister’s Award for Excellence in Health and Medical Research.
Sharon McGowan
Sharon is the Chief Executive Officer of RANZCP. Having spent her career in the health and not-for-profit sector, Sharon has a wealth of leadership and governance experience gained over the past 30 years.
She is a skilled communicator, with a background in health service management, community engagement, advocacy, culture transformation and philanthropy. Originally trained as a registered nurse, Sharon has worked in Australia and the UK with a range of health, public sector and not-for-profit organisations.
She is an experienced Board Director and currently Chair of the Australian Living Evidence Consortium, a group whose vision is to accelerate the application of medical research to actionable guidance for front line clinicians using a “living” approach to evidence synthesis. Prior to joining the College, Sharon was CEO of the National Stroke Foundation for 7 years, growing the Foundations’ revenue and impact. Sharon is the immediate past Chair of the Australian Chronic Disease Prevention Alliance and the National COVID19 Clinical Evidence Taskforce Steering Committee.
Sharon holds a Master of Business Administration from Cranfield University in the UK, is a graduate of the Australian Institute of Company Directors and has attended two short courses at Harvard Business School.
Sharon is the Chief Executive Officer of RANZCP. Having spent her career in the health and not-for-profit sector, Sharon has a wealth of leadership and governance experience gained over the past 30 years.
She is a skilled communicator, with a background in health service management, community engagement, advocacy, culture transformation and philanthropy. Originally trained as a registered nurse, Sharon has worked in Australia and the UK with a range of health, public sector and not-for-profit organisations.
She is an experienced Board Director and currently Chair of the Australian Living Evidence Consortium, a group whose vision is to accelerate the application of medical research to actionable guidance for front line clinicians using a “living” approach to evidence synthesis. Prior to joining the College, Sharon was CEO of the National Stroke Foundation for 7 years, growing the Foundations’ revenue and impact. Sharon is the immediate past Chair of the Australian Chronic Disease Prevention Alliance and the National COVID19 Clinical Evidence Taskforce Steering Committee.
Sharon holds a Master of Business Administration from Cranfield University in the UK, is a graduate of the Australian Institute of Company Directors and has attended two short courses at Harvard Business School.
